Trial Details
RECRUITINGBasic Information
| Clinical ID | c1182 |
|---|---|
| Identifier | NCT06095128 |
| Trial Title | A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab|DRUG: Tofacitinib |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-06-12 |
|---|---|
| Primary Completion Date | 2027-07-09 |
| Completion Date | 2027-07-09 |